Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human ATP2C1 Antibodies:
anti-Rat (Rattus) ATP2C1 Antibodies:
anti-Mouse (Murine) ATP2C1 Antibodies:
Go to our pre-filtered search.
Human Monoclonal ATP2C1 Primary Antibody for IHC, ELISA - ABIN1724719
Majore, Biolcati, Barboni, Cannistraci, Binni, Crisi, Picardo, Grammatico: ATP2C1 gene mutation analysis in Italian patients with Hailey-Hailey disease. in The Journal of investigative dermatology 2005
Show all 2 Pubmed References
Human Monoclonal ATP2C1 Primary Antibody for IF, IP - ABIN565309
Grice, Vetter, Faddy, Kenny, Roberts-Thomson, Monteith: Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231. in The Journal of biological chemistry 2010
Show all 2 Pubmed References
Human Monoclonal ATP2C1 Primary Antibody for IHC, ELISA - ABIN965621
Yokota, Sawamura: Hailey-Hailey disease with affective disorder: report of a case with novel ATP2C1 gene mutation. in Journal of dermatological science 2006
Show all 2 Pubmed References
Human Polyclonal ATP2C1 Primary Antibody for IHC, WB - ABIN4254942
Pacheco-Rodriguez, Kumaki, Steagall, Zhang, Ikeda, Lin, Billings, Moss: Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene. in Journal of immunology (Baltimore, Md. : 1950) 2009
review of the literature about the mutations occurring on the ATP2C1 gene and summarize how they are distributed along the gene and how missense mutations affect protein expression
The Secretory Pathway Ca(2 (show CA2 Antibodies)+) -ATPases SPCA1 and SPCA2 (show ATP2C2 Antibodies) are strongly induced under osteogenic conditions that elicit microcalcifications. SPCA (show F7 Antibodies) gene expression is significantly elevated in breast cancer subtypes that are associated with microcalcifications.
xpressing either wild-type or mutant forms of SLC30A10 was sufficient to inhibit the effect of ATP2C1 in response to Mn challenge in both zebrafish embryos and HeLa cells. These findings suggest that either activating ATP2C1 or restoring the Mn-induced trafficking of ATP2C1 can reduce Mn accumulation, providing a possible target for treating HMDPC.
SPCA1a is highly sensitive to the lipid environment and that several SERCA (show ATP2A3 Antibodies) inhibitors, including thapsigargin (Tg), also block SPCA1a activity, although at higher concentrations only. There were differences in the relative contribution of Tg side chains in the inhibition of SERCA1a (show ATP2A1 Antibodies) versus SPCA1a.
In this study, direct DNA sequencing was used to identify ATP2C1 gene mutations in four Chinese families and two sporadic cases with Hailey-Hailey disease.
Two novel ATP2C1 mutations have been found in two unrelated Chinese patients with Hailey-Hailey disease pedigree.
Besides the level of functional ATP2C1 protein, levels of other ATPase (show DNAH8 Antibodies) proteins may influence expressivity of the disease and may also contribute to atypical presentations in three male members of the Hailey Hailey disease family.
This is the first genetic report of HHD from Lebanon in which we identified three novel mutations in ATP2C1 and shed light on the molecular mechanisms and pathogenesis of HHD by linking stress signals like heat shock to the observed phenotypes
We speculate that a novel pathogenic mechanism involving SPCA1, p63 (show RPE65 Antibodies), and IRF6 (show IRF6 Antibodies) may play a role in the skin lesions occurring in HHD.
Data suggest that calcium ATPase (show CA-P60A Antibodies) ATP2C1 gene expression is influenced by an overlapping protein asteroid homolog 1 ASTE1 (show ASTE1 Antibodies) gene.
The timing, magnitude of TMEM165 (show TMEM165 Antibodies) expression and its Golgi location supports a role for this Golgi Ca2 (show CA2 Antibodies)+/H+ antiporter as a contributor to mammary Golgi calcium transport needs, in addition to the better-characterized roles of SPCA 1 and 2.
loss of the Golgi Ca(2 (show CA2 Antibodies)+) pump causes Golgi stress, expansion of the Golgi, increased apoptosis, and embryonic lethality and demonstrates that SPCA1 haploinsufficiency causes a genetic predisposition to cancer.
The synthesized siPMR1 can significantly silence the expression of PMR1 and promote the secretion of insulin (show INS Antibodies) in the islet cells in vitro.
Impaired cellular divalent calcium ion Ca2 (show CA2 Antibodies)+ homeostasis and/or the altered targeting of organellar proteins under conditions of SPCA1 knockdown highlight the importance of SPCA1 function for normal neural differentiation.
The protein encoded by this gene belongs to the family of P-type cation transport ATPases. This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium ions. Defects in this gene cause Hailey-Hailey disease, an autosomal dominant disorder. Alternatively spliced transcript variants encoding different isoforms have been identified.
ATPase, Ca++ transporting, type 2C, member 1
, ATPase 2C1
, Calcium-transporting ATPase type 2C member 1
, calcium-transporting ATPase type 2C member 1-like
, ATP-dependent Ca(2+) pump PMR1
, ATPase, Ca(2+)-sequestering
, calcium-transporting ATPase type 2C member 1
, secretory pathway Ca2+/Mn2+ ATPase 1
, ATPase, Ca++-sequestering
, calcium-transporting ATPase 2C1
, secretory pathway Ca(2+)-ATPase 1
, secretory pathway Ca(2+)-transporting ATPase